MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 375 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,106,000 | -71.7% | 9,687 | -68.0% | 0.01% | -71.1% |
| Q1 2015 | $3,909,000 | +15.0% | 30,288 | -11.3% | 0.04% | +15.4% |
| Q4 2014 | $3,400,000 | -11.8% | 34,137 | -12.5% | 0.04% | -15.2% |
| Q3 2014 | $3,857,000 | +28.3% | 39,015 | 0.0% | 0.05% | +31.4% |
| Q2 2014 | $3,007,000 | +19.8% | 39,015 | 0.0% | 0.04% | +16.7% |
| Q1 2014 | $2,511,000 | +2.8% | 39,015 | +1.9% | 0.03% | +7.1% |
| Q4 2013 | $2,442,000 | – | 38,270 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |